Elicio Therapeutics Competitors and Similar CompaniesClear all

Elicio Therapeutics's competitors and similar companies include NextCure.

	Elicio Therapeutics Elicio Therapeutics (formerly known as Vedantra Pharmaceuticals) is an immuno-oncology company developing vaccines and immunotherapies for aggressive solid and hematologic cancers.	NextCure NextCure is a biopharmaceutical company focused on discovering and developing next-generation immuno-oncology-based drugs.
Founding Date	Founding Date 2011	Founding Date 2015
Type	Type Public	Type Public
Tags	Tags Technology drug development oncology pharma therapy	Tags Healthcare Technology biotech drug development oncology pharma platform therapy
Locations	Locations Cambridge, US HQ	Locations Beltsville, US HQ
Employees	Employees 22	Employees N/A
Valuation ($)	Valuation ($) 47.5 m	Valuation ($) 39.2 m
Financial
Net income	Net income ($39.6m) (FY, 2025)	Net income ($55.8m) (FY, 2025)
Funding
Total funding raised	Total funding raised $ 150.3m	Total funding raised $ 160m

For sources of this data, please see the company profile

Beltsville, US

NextCure is a biopharmaceutical company focused on discovering and developing next-generation immuno-oncology-based drugs.

Financial